Bellevue Group AG increased its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 2.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 86,232 shares of the conglomerate’s stock after purchasing an additional 1,922 shares during the quarter. Bellevue Group AG’s holdings in Danaher were worth $21,534,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in DHR. Tsfg LLC grew its holdings in Danaher by 733.3% during the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock valued at $25,000 after buying an additional 88 shares in the last quarter. Cape Investment Advisory Inc. bought a new stake in shares of Danaher during the 4th quarter worth approximately $25,000. Redmont Wealth Advisors LLC bought a new stake in Danaher during the 1st quarter valued at $30,000. Wetzel Investment Advisors Inc. bought a new position in shares of Danaher in the 4th quarter worth $29,000. Finally, Rakuten Securities Inc. purchased a new position in Danaher during the 4th quarter worth $36,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Insider Buying and Selling at Danaher
In other Danaher news, Director Alan G. Spoon sold 708 shares of the business’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total value of $172,454.64. Following the completion of the transaction, the director now directly owns 116,202 shares in the company, valued at approximately $28,304,483.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Alan G. Spoon sold 708 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $243.58, for a total transaction of $172,454.64. Following the completion of the sale, the director now directly owns 116,202 shares of the company’s stock, valued at approximately $28,304,483.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Rainer Blair sold 19,085 shares of the company’s stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $255.00, for a total transaction of $4,866,675.00. Following the sale, the chief executive officer now directly owns 115,995 shares of the company’s stock, valued at $29,578,725. The disclosure for this sale can be found here. In the last three months, insiders sold 84,775 shares of company stock worth $21,802,690. Insiders own 11.10% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Research Report on DHR
Danaher Price Performance
Shares of DHR stock traded up $3.82 during midday trading on Friday, reaching $273.91. 2,810,147 shares of the company traded hands, compared to its average volume of 3,314,172. The firm’s 50 day simple moving average is $255.16 and its two-hundred day simple moving average is $249.35. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $277.72. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.51. The firm has a market cap of $197.82 billion, a PE ratio of 46.43, a price-to-earnings-growth ratio of 4.24 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.15. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The firm had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the previous year, the firm posted $2.05 EPS. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. On average, equities research analysts expect that Danaher Co. will post 7.59 EPS for the current fiscal year.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, July 26th. Shareholders of record on Friday, June 28th were issued a $0.27 dividend. The ex-dividend date was Friday, June 28th. This represents a $1.08 annualized dividend and a yield of 0.39%. Danaher’s dividend payout ratio (DPR) is presently 18.31%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is Crypto Cool Again? What Stocks You Should Be Watching
- What Do S&P 500 Stocks Tell Investors About the Market?
- Why Call Options Volume for These 2 Stocks Spiked Together
- Profitably Trade Stocks at 52-Week Highs
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.